This country profile provides an overview of Senegal’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profiles
Priorities for progress in Senegal
- Senegal should continue to build the preventive chemotherapy programme for all of the five diseases, with systematic annual high-coverage implementation of all components, in all risk groups, as recommended by WHO.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Treatment maintained its coverage of 71% from 2016 to 2017.
Treatment coverage increased from 15% in 2016 to 70% in 2017.
Treatment coverage decreased from 63% in 2016 to 57% in 2017.
Treatment coverage increased from 35% in 2016 to 91% in 2017.
Treatment coverage decreased from 69% in 2016 to 48% in 2017.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Senegal.